Related Experiment Videos
Application of proteomic technologies in the drug development process.
Jennie L Walgren1, David C Thompson
1Worldwide Safety Sciences, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA.
Toxicology Letters
|April 20, 2004
Summary
Proteomics is crucial for drug discovery, aiding in target identification, biomarker discovery for efficacy and toxicity, and understanding drug mechanisms. Integrating proteomics with genomics and metabolomics offers a comprehensive systems biology approach.
Area of Science:
- Biochemistry
- Pharmacology
- Biotechnology
Background:
- Proteins are primary targets in drug discovery.
- Pharmaceutical companies increasingly utilize proteomics.
- Proteomics offers diverse applications in drug development.
Purpose of the Study:
- To outline the role of proteomics in drug discovery.
- To detail applications in target identification, validation, and biomarker discovery.
- To highlight the integration of proteomics with other 'omics' for a systems biology approach.
Main Methods:
- Proteomics for target identification and validation.
- Biomarker discovery for efficacy and toxicity.
- Analysis of protein-protein interactions.
- Integration with metabolomics and genomics.
Main Results:
- Proteomics enables identification of disease-related proteins as therapeutic targets.
- Efficacy and toxicity biomarkers are identified from biological fluids.
- Proteomics elucidates drug mechanisms and interactions.
Conclusions:
- Proteomics is integral to modern drug discovery and development.
- Biomarker identification enhances therapeutic efficacy and safety assessment.
- A systems biology approach combining 'omics' technologies optimizes drug development.